APA način citiranja

Sasaki, H., Murakami, Y., Uemura, K., Sudo, T., Hashimoto, Y., Kondo, N., & Sueda, T. (2014). Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy. Nature Publishing Group.

Čikaški stil citiranja

Sasaki, H., Y. Murakami, K. Uemura, T. Sudo, Y. Hashimoto, N. Kondo, i T. Sueda. Concurrent Analysis of Human Equilibrative Nucleoside Transporter 1 and Ribonucleotide Reductase Subunit 1 Expression Increases Predictive Value for Prognosis in Cholangiocarcinoma Patients Treated With Adjuvant Gemcitabine-based Chemotherapy. Nature Publishing Group, 2014.

MLA način citiranja

Sasaki, H., et al. Concurrent Analysis of Human Equilibrative Nucleoside Transporter 1 and Ribonucleotide Reductase Subunit 1 Expression Increases Predictive Value for Prognosis in Cholangiocarcinoma Patients Treated With Adjuvant Gemcitabine-based Chemotherapy. Nature Publishing Group, 2014.